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Abstract
Background: Garcinia kola is used in traditional medicine in various parts of Africa including Nigeria for the
amelioration of hypertension, cough, diabetes, sickle cell anemia, bacterial and fungal infections amongst others. The
prophylactic and therapeutic efficacy of Garcinia kola biflavonoid fractions (GKBF); root bark (RBBF), stem bark (SBBF) and
seed (SBF)) on the lipid profile and kidney function of Poloxamer 407 (P407) induced hyperlipidemic rats were determined.
Methods: Hyperlipidemia was induced by a single intraperitoneal dose of P407 after 19 days in the prophylactic group
and after every 48 h in therapeutic group for 21 days. Atorvastatin (standard drug) and the GKBF were administered to
different subgroups before induction in Prophylactic group and after induction in therapeutic group. Experimental
animals were euthanized after day 21 of the study and blood samples collected for the evaluation of lipid levels and
kidney function.
Results: All Prophylactic and therapeutic group treated sub-groups had significantly (p < 0.05) lower serum
concentrations of total cholesterol (TC), triglycerides (TG) and low density lipoprotein cholesterol (LDL-c) when
compared to hyperlipidemic control. The RBBF and SBBF increased the levels of high density lipoprotein cholesterol
(HDL-c). SBBF and SBF significantly (p < 0.05) increased HDL-c/TC ratio. The LDL-c/HDL-c and log (TG/HDL-c) level were
lowered by the extracts except in the therapeutic group where only the SBF reduced log (TG/HDL-c). Kidney function
test results in all groups showed no significant (p > 0.05) change in urea and creatinine concentrations.
Conclusion: This study shows that Garcinia kola biflavonoid fraction has potential prophylactic and therapeutic efficacy
in the management of hyperlipidemia.
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Background
Plants appear to be the major source of drugs for the
majority of the world’s population, with substances
derived from higher plants constituting about a quarter
of all prescribed medicines [1]. Several herbal medicines
have advanced to clinical use in modern times. Garcinia
kola a dicotyledonous plant, species of flowering plant in
the Clusiaceae or Guttiferae family is one of such plants.
It is a medium-sized tree mostly about 12 m high and
sometimes up to 28 m in height. The bark is thick and
brownish, yielding a yellow juice. The leaves are broadly
elliptic, acute or shortly acuminate at the apex. The
fruits are reddish yellow globular berries exhaling an
apricot scent and about 6 cm in diameter with 2 to 4
brown seeds embedded in an orange coloured pulp. The
seeds are bitter and chewed like kola nuts. Its natural
habitat is subtropical or tropical moist lowland forests
found in west and central Africa in countries like Benin,
Cameroon, Democratic Republic of the Congo, Ivory
Coast, Gabon, Ghana, Liberia, Nigeria (South Western
and South Eastern parts), Senegal and Sierra Leone.
In Nigeria, it is commonly known as bitter kola due to
its bitter taste, male kola due to reported aphrodisiac
properties, Orogbo (Yoruba), Aku ilu (Igbo) and Namijin
goro (Hausa). It is also called a “wonder plant” because
all of its parts have been found to be of medicinal
importance [2].
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Biological activity reported for different plant part
extracts include; antidiabetic activity, antihepatotoxic
activity, antimicrobial activity, antioxidant activity [3–6].
Most of Garcinia kola biological activities have been
attributed to the presence of a biflavonoid complex.
Poloxamer 407 (P407), a nonionic surfactant is a tri-
block copolymer comprising of polyoxyethylene and
polyoxypropylene units. It is known for its biocompatibil-
ity and potential to deliver different drugs for a variety of
disease states [7] and as a barrier in preventing postsurgi-
cal adhesions [8]. It has an unusual thermoreversible
properties, it is liquid at room temperature while it self-
assembles into micelles then aggregate into a gel at body
temperature. These temperature-dependent micellization
and gelation properties have led to the widespread use of
P407 in personal care products such as mouthwashes,
deodorants, and skin care products and also as an excipi-
ent in a variety of pharmaceutical preparations. Johnston
et al. [7] showed that one intramuscular or intraperitoneal
injection of P407 causes dose-dependent hyperlipidemia
in rats, increasing plasma triglyceride (TG) more than 60
fold and cholesterol 8 fold and since then has been a
growing model in different hyperlipidemic studies.
Hyperlipidemia is one of the greatest risk factors con-
tributing to the prevalence and severity of cardiovascular
disease and cardiovascular disease is regarded as a lead-
ing cause of death worldwide [9]. Cardiovascular disease
covers a wide array of disorders, including diseases of
the cardiac muscle and of the vascular system supplying
the heart, brain, and other vital organs [10].
Hyperlipidemia is a lipid disorder hence alters lipid
profile. It is characterized by elevated serum total chol-
esterol, low density lipoprotein, very low density lipopro-
tein and decreased high density lipoprotein levels [11]
though may be asymptomatic. Hyperlipidemia causes
atherosclerotic cardiovascular disease which eventually
affects organs such as the kidney, leading to glomerular
injury, interstitial fibrosis and tubular atrophy, ischemic
nephropathy and End Stage Renal Disease [12]. Increase
in body weight and certain organs such as liver and
spleen are also associated with hyperlipidemia due to
increase in cholesterol and triglycerides and infiltration
of these lipids to the organs respectively. This study was
therefore carried out to explore the possible efficacy of
prophylactic and therapeutic administration of G. kola
(root bark, stem bark and seed) biflavonoid fractions on
hyperlipidemic rats in relation to kidney function, body
and organ weight change.
Methods
Collection of plant material and identification
Root bark, stem bark, and seed of Garcinia kola were
collected from Abak, Akwa Ibom state, Nigeria, in the
month of August, 2012. The plant was identified and
authenticated by Mr. Umar Shehu Gallah, a plant
taxonomist at the herbarium unit of Biological Sciences
Department, Ahmadu Bello University, Zaria, where
voucher specimen number 1783 was given and deposited
for future reference.
Plant preparation and extraction
The root bark were washed and sliced, the seeds peeled
and sliced and both separately pulverized with an elec-
tric blender and air-dried in the laboratory at room
temperature alongside the stem bark which was coarsely
ground after drying. Biflavonoid fractions of the coarsely
ground root bark, stem bark and seed were respectively
extracted by the method of Iwu et al. [3].
Animals
A total of 60 apparently healthy Wistar albino rats of both
sexes weighing between 150 and 200 g obtained from the
National Institute for Trypanosomiasis Research, Kaduna,
Nigeria were acclimatized for a period of 2 weeks and
used for the experiment. The rats were fed with water and
pelleted growers’ mash (Vital feed ®, Nigeria) ad libitum.
The animals were properly handled according to the
guidelines of the Animal Ethical Committee of the
University (Ahmadu Bello University, Zaria, Nigeria)
which is in compliance with NIH Guide for Care and
Use of Laboratory Animals (pub. No. 85–23, Revised
1985).
Acute toxicity study (LD50)
The mean lethal dose (LD50) of Garcinia kola (root bark,
stem bark and seed) biflavonoid fractions were deter-
mined by a method described by Lorke [13].
Preparation of standard drug
Atorvastatin (Pfizer Ireland pharmaceuticals, Ireland) was
purchased in a tablet form at strength 20 mg. Tablets were
crushed into powder, dissolved in distilled water and
administered orally.
Induction of hyperlipidemia
P407 (Lutrol F127; BASF, Ludwigshafen, Germany) was
used as the inducing agent. Prior to the administration,
P407 was dissolved in distilled water and refrigerated
overnight to facilitate its dissolution. Needles and syrin-
ges to be used for administration were also cooled to
prevent gelation within the syringe during injection [14].
The induction of hyperlipidemia was confirmed by col-
lection of blood samples from the induced animals 2 h
post-P 407 administration for assay of total cholesterol
and triglyceride concentrations. Rats with total choles-
terol and triglyceride levels above200mg/dl and 160 mg/
dl respectively were considered hyperlipidemic [15].
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Animal grouping
The rats were randomly divided into 2 major groups
(Prophylactic and Therapeutic); with a total of 10
sub-groups comprising of 6 rats each as previously
described by Ameh et al. [16]. Briefly, sub-groups 3–6
were administered atorvastatin, root bark, stem bark
and seed biflavonoid fractions respectively for 19 days
and on the 19th day, injected with P407 (500 mg/kg b. wt)
and sacrificed 48 h after (Prophylactic study) while sub-
groups 7–10 were administered P407 (500 mg/kg b. wt) at
48 h interval for 21 days; treatment commenced 2 h after
induction (Therapeutic Study).
Prophylactic study (Group one)
 Group I: fed normal chow and distilled water only
for 21 days (NC).
 Group II: induced using P407 without treatment
(HC).
 Group III: treated with Atorvastatin (ATV) at
10 mg/kg body weight/day for 19 days and then
induced for 2 days
 Group IV: treated with root bark biflavonoid
fraction (RBBF) at 200 mg/kg body weight/day for
19 days and then induced for 2 days
 Group V: treated with stem bark biflavonoid
fraction (SBBF) at 200 mg/kg body weight/day for
19 days and then induced for 2 days
 Group VI: treated with seed biflavonoid fraction
(SBF) at 200 mg/kg body weight/day for 19 days and
then induced for 2 days
Therapeutic study (Group two)
 Group I: fed normal chow and distilled water only
for 21 days (NC).
 Group II: induced using P407 without treatment
(HC).
 Group VII: induced and treated with ATV at 10 mg/
kg body weight/day for 21 days.
 Group VIII: induced and treated with RBBF at
200 mg/kg body weight/day for 21 days.
 Group IX: induced and treated with SBBF at
200 mg/kg body weight/day for 21 days
 Group X: induced and treated with SBF at 200 mg/
kg body weight/day for 21 days
The rats were routinely weighed on a weekly basis to
facilitate administration of the correct dose of P407, G.
kola biflavonoid fractions and standard drug (Atorvastatin)
and to monitor relative weight change. All drugs were
administered Per Os once daily with the exception of P407
which was administered intraperitoneally. The rats were
also monitored for clinical signs and death.
Collection and preparation of sera samples
All experimental animals were anesthetized at the end of
the 21-day experimental period using the chloroform-
inhalation technique and bled by cardiac puncture.
Serum was harvested into plain bottles from the coagu-
lated blood by centrifugation at 3000 rpm for 15 min.
The organs (heart, liver, kidney and spleen) were also
harvested and weighed.
Determination of parameters
Determination of serum lipid profiles and kidney function
parameters
Total cholesterol (TC) and Triglycerides (TG) levels were
determined using the Randox® kit (Randox Laboratories
Limited UK), high-density lipoprotein-cholesterol (HDL-c)
level was determined using ELITech® kit (ELITech Clinical
Systems, France), low-density lipoprotein cholesterol
(LDL-c) was determined by the protocol of Friedewald
[17] using the equation: LDL-c (mg/dl) = TGL/5 –
HDL-c, and atherogenic risk factor was calculated
using formula of Dobiasova and Frohlich [18]. Serum
creatinine and urea concentrations were evaluated
using commercial kits: Randox® kit (Randox Laboratories
Limited UK).
Body weight change and organ weight
The body and organ weights were measured using sensi-
tive weighing balance to monitor the change in body





Data are expressed as mean ± standard deviation (SD)
and were analyzed by the analysis of variance (ANOVA).
The difference between the various biflavonoid fractions
and animal groups were compared using the Duncan
Multiple Range Test. P value less than 0.05 was consid-
ered significant (p < 0.05).
Results
Changes in lipid profile
The Prophylactic effect of Garcinia kola biflavonoid
fractions (root bark, stem bark and seed) on lipid profile
showed significant (p < 0.05) decrease in serum concen-
trations of total cholesterol (TC), triglycerides (TG) and
low density lipoprotein cholesterol (LDL-c) in all treated
groups compared to hyperlipidemic control with the
seed having the most significant (p < 0.05) reduction in
TC (79 %) and TG (67 %) levels compared to other bifla-
vonoid fractions. However, only the root bark and stem
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bark fractions significantly (p < 0.05) increased high
density lipoprotein cholesterol (HDL-c) (Table 1).
Therapeutic study (Table 2) showed all treatments
significantly (p < 0.05) reduced serum TC, TG and LDL-
c concentrations when compared to hyperlipidemic
control with the root bark and stem bark having the
most reduction in TC (77 and 78 % respectively) when
compared to all other induced treated groups. HDL-c
concentration was significantly (p < 0.05) increased by
only the seed fraction.
Atherogenic risk predictor indices
Serum atherogenic risk predictor indices of the prophylac-
tic study (Table 1) showed only biflavonoid fractions
significantly (p < 0.05) increased HDL-c/TC ratio and
significantly (p < 0.05) reduced log (TG/HDL-c) ratio
when compared to atorvastatin and hyperlipidemic con-
trol while all treatments (atorvastatin and biflavonoid frac-
tions) significantly (p < 0.05) reduced LDL-c/HDL-c ratio.
The Therapeutic effect of oral administration of
Garcinia kola biflavonoid fractions on serum athero-
genic risk predictor indices of P407 induced hyperlip-
idemic rats (Table 2) showed all treatments significantly
(p < 0.05) increased HDL/TC ratio except the root biflavo-
noid fraction when compared to hyperlipidemic control.
LDL-c/HDL-c ratio of all treated groups was significantly
(p < 0.05) lower than that of hyperlipidemic control but
only the seed and atorvastatin treated groups had signifi-
cantly (p < 0.05) lower log (TG/HDL-c) when compared
to other groups.
Kidney function test
No significant (p > 0.05) difference was observed in
serum creatinine and urea concentrations of all the
groups in both prophylactic and therapeutic studies
(Tables 3 and 4).
Change in body weight
In the prophylactic study there was a significant (p > 0.05)
increase in the body weight for root bark biflavonoid
treated group compared to all other groups (Table 5)
while in the therapeutic study, the seed biflavonoid frac-
tion significantly (p > 0.05) reduced body weight compared
to all the groups except stem bark fraction (Table 6).
Percentage organ weights
In the prophylactic study, liver and spleen weights were
significantly (p < 0.05) reduced by atorvastatin and all
biflavonoid fractions. However, there was no significant
(p > 0.05) change in kidney weight of all the groups
(Table 7).
The therapeutic study showed no significant (p > 0.05)
change in heart and kidney weights of all the groups
(Table 8).
Discussion
Poloxamer 407, a nonionic surfactant is well known to
induce dose dependant hyperlipidemia [19] by inhibiting
capillary (heparin releasable) lipoprotein lipase (LPL),
the major enzyme responsible for the hydrolysis of
plasma lipoprotein triglycerides (TG) and indirectly
stimulating the activity of 3-hydroxy-3-methylglutaryl
CoA (HMG CoA) reductase, the rate limiting enzyme in
cholesterol synthesis, thereby leading to hypertriglyc-
eridemia and hypercholesterolemia respectively. It is
nontoxic and safe for chronic administration and long
term studies [20]. The significant (P < 0.05) increase in
TC (25 fold), TG (11 fold) and LDL-c (23 fold) seen in
hyperlipidemic models administered intraperitoneally
500 mg/kg body weight of P407 [21] indicates successful
induction of hyperlipidemia.
Hyperlipidemia is responsible for the onset and pro-
gression of atherosclerosis, a major risk factor in the
development of coronary heart diseases (CHDs) such as
ischemic heart disease, myocardial infarction and stroke
Table 1 Prophylactic effect of Garcinia kola biflavonoid fractions on lipid profile and atherogenic risk predictor indices of P407 induced
hyperlipidemic albino rats
Group (n = 6) TC (mg/dl) TG (mg/dl) HDL-c (mg/dl) LDL-c (mg/dl) HDL-c/TC LDL-c/HDL-c Log(TG/HDL-c)
NC 59.36 ± 7.20a 37.73 ± 8.45a 34.23 ± 5.33a 17.9 ± 5.55a 0.56 ± 0.06d 0.53 ± 0.18a −0.32 ± 0.16a
P407 642.25 ± 50.29e 946.13 ± 21.09f 46.33 ± 13.92a 406.69 ± 33.35c 0.07 ± 0.02a 9.16 ± 1.89b 1.00 ± 0.07d
ATV + P407 166.62 ± 15.60b 625.33 ± 82.03e 25.39 ± 5.22a 16.17 ± 5.12a 0.15 ± 0.02a 0.68 ± 0.23a 0.98 ± 0.09d
RBBF + P407 234.17 ± 40.00c 420.00 ± 28.00c 103.05 ± 13.49b 47.12 ± 15.70a 0.44 ± 0.02c 0.45 ± 0.10a 0.25 ± 0.03b
SBBF + P407 292.72 ± 7.80d 508.67 ± 29.14d 91.90 ± 12.58b 99.08 ± 11.76b 0.31 ± 0.04b 1.10 ± 0.29a 0.37 ± 0.04b
SBF + P407 135.10 ± 27.02b 312.67 ± 77.11b 37.26 ± 18.13a 35.30 ± 13.13a 0.27 ± 0.10b 1.19 ± 0.88a 0.59 ± 0.15c
Values are means ± Standard deviation
Values with different superscripts down the column differ significantly (P < 0.05)
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats, ATV + P407 10 mg of Atorvastatin + P407 Induced Hyperlipidemic Rats, RBBF + P407 200 mg of Root
bark Biflavonoid Fraction + P407 Induced Hyperlipidemic Rats, SBBF + P407 200 mg of Stem bark Biflavonoid Fraction + P407 Induced Hyperlipidemic Rats, SBF +
P407 200 mg of Seed Biflavonoid Fraction + P407 Induced Hyperlipidemic Rats, TC Total cholesterol, TG Triglycerides, HDL-c High density lipoprotein cholesterol,
LDL-c Low density lipoprotein cholesterol
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[22]. CHDs are responsible for about 17 million deaths
in the world [23].
In clinical practice, effective and intensive lipid-lowering
is important in order to reduce and prevent [24] CHDs.
Garcinia kola (root bark, stem bark and seed) biflavonoid
fractions significantly (p < 0.05) reduced TC, TG and
LDL-c concentrations in both studies. These reductions in
TC, TG and LDL levels suggest the ameliorative effect of
Garcinia kola fractions in hyperlipidemia (Tables 1 and 2).
The elevation of TC concentration in this study was
achieved by the indirect stimulation of HMG CoA
reductase following an intraperitoneal (i.p) injection
of P407 [19]. Hence the possible TC lowering effects
of Garcinia kola (root bark, stem bark and seed)
biflavonoid fractions could be attributed to decreased
activity of hepatic HMG CoA reductase and/or stimula-
tion of cholesterol-7-alpha-hydroxylase, which converts
cholesterol into bile acids. Besides, the standard drug
(Atorvastatin) used in this study inhibits HMG CoA
reductase, a rate limiting enzyme in the biosynthesis of
cholesterol. The results obtained in this work conform to
earlier report by Patel et al. [25] that flavonoids possess
antilipidemic activity.
Increase in TG concentration following P407 i.p. injec-
tion results primarily from an inhibition of TG degrad-
ation, P407 directly inhibits capillary lipoprotein lipase
(LPL) responsible for plasma TG hydrolysis [19].
Although the standard drug might not decrease TG con-
centrations by activating lipoprotein lipase, the biflavo-
noid fractions from Garcinia kola could have reduced
TG levels by either activating endothelium bound lipo-
protein lipase which hydrolyses the triglyceride into fatty
acid hence decreasing triglyceride levels as seen in a
report by Sikarwar and Patil [26].
LDL (low density lipoprotein) is responsible for trans-
porting cholesterol to the body cells. It transports about
60–70 % of total cholesterol. Therefore, an increase in
TC level consequently increases LDL-c. The increased
Table 2 Therapeutic effect of Garcinia kola biflavonoid fractions on lipid profile and atherogenic risk predictor indices of P407
induced hyperlipidemic albino rats
Group (n = 6) TC (mg/dl) TG (mg/dl) HDL-c (mg/dl) LDL-c (mg/dl) HDL-c/TC LDL-c/HDL-c Log(TG/HDL-c)
NC 59.36 ± 7.20a 37.73 ± 8.45a 34.23 ± 5.33abc 17.59 ± 5.55ab 0.56 ± 0.06e 0.53 ± 0.18a −0.32 ± 0.16a
P407 642.25 ± 50.29d 946.13 ± 21.09e 46.33 ± 13.92bc 406.69 ± 33.35c 0.07 ± 0.02a 9.16 ± 1.89b 1.00 ± 0.07d
P407+ ATV 243.18 ± 27.02c 737.33 ± 106.93d 53.91 ± 7.94cd 41.81 ± 4.36b 0.22 ± 0.01cd 0.79 ± 0.16a 0.78 ± 0.02c
P407 + RBBF 149.78 ± 11.80b 611.33 ± 21.39bc 17.58 ± 8.42a 9.94 ± 0.77a 0.12 ± 0.05ab 0.66 ± 0.30a 0.99 ± 0.02d
P407 + SBBF 139.60 ± 15.60b 532.00 ± 85.16b 23.29 ± 6.80ab 9.91 ± 4.84a 0.17 ± 0.07bc 0.50 ± 0.42a 0.95 ± 0.12d
P407 + SBF 239.68 ± 41.27c 686.00 ± 77.95cd 74.92 ± 29.98d 26.56 ± 4.60ab 0.31 ± 0.07d 0.41 ± 0.19a 0.56 ± 0.08b
Values are means ± Standard deviation
Values with different superscripts down the column differ significantly (P < 0.05)
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats, P407 + ATV P407 Induced Hyperlipidemic Rats + 10 mg of Atorvastatin, P407 + RBBF P407 Induced
Hyperlipidemic Rats + 200 mg of Root bark Biflavonoid Fraction, P407+ SBBF P407 Induced Hyperlipidemic Rats + 200 mg of Stem bark Biflavonoid Fraction, P407
+ SBF P407 Induced Hyperlipidemic Rats + 200 mg of Seed Biflavonoid Fraction, TC Total cholesterol, TG Triglycerides, HDL-c High density lipoprotein cholesterol,
LDL-c Low density lipoprotein cholesterol
Table 3 Prophylactic effect of Garcinia kola biflavonoid fractions
on kidney function parameters of P407 induced hyperlipidemic
albino rats
Group (n = 6) Creatinine (mg/dl) Urea (mg/dl)
NC 0.54 ± 0.17a 31.86 ± 7.20 a
P407 0.59 ± 0.19a 33.75 ± 5.15 a
ATV + P407 0.51 ± 0.20a 35.90 ± 2.53 a
RBBF + P407 0.51 ± 0.34a 44.18 ± 7.47a
SBBF + P407 0.50 ± 0.17a 36.72 ± 4.79 a
SBF + P407 0.56 ± 0.17a 34.51 ± 4.17 a
Values are means ± Standard deviations
Values with different superscripts down the column differ
significantly (p < 0.05)
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats (500 mg/kg), ATV +
P407 Atorvastatin (10 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg),
RBBF + P407 Root bark Biflavonoid Fraction (200 mg/kg) + P407 Induced
Hyperlipidemic Rats (500 mg/kg), SBBF + P407 Stem bark Biflavonoid Fraction
(200 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg), SBF + P407 Seed
Biflavonoid Fraction (200 mg/kg) + P407 Induced Hyperlipidemic
Rats (500 mg/kg)
Table 4 Therapeutic effect of Garcinia kola biflavonoid fractions
on kidney function parameters of P407 induced hyperlipidemic
albino rats
Group (n = 6) Creatinine (mg/dl) Urea (mg/dl)
NC 0.54 ± 0.17a 31.86 ± 7.20 a
P407 0.59 ± 0.19a 33.75 ± 5.15 a
P407 + ATV 0.51 ± 0.34a 33.67 ± 7.52a
P407 + RBBF 0.43 ± 0.17a 36.26 ± 2.32a
P407 + SBBF 0.57 ± 0.39a 35.62 ± 3.31 a
P407 + SBF 0.48 ± 0.19a 36.88 ± 1.88 a
Values are means ± Standard deviation
Values with different superscripts down the column differ
significantly (p < 0.05)
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats (500 mg/kg), P407
+ ATV P407 Induced Hyperlipidemic Rats (500 mg/kg) + Atorvastatin (10 mg/
kg), P407 + RBBF P407 Induced Hyperlipidemic Rats (500 mg/kg) + Root bark
Biflavonoid Fraction (200 mg/kg), P407 + SBBF P407 Induced Hyperlipidemic
Rats (500 mg/kg) + Stem bark Biflavonoid Fraction (200 mg/kg), P407 + SBF
P407 Induced Hyperlipidemic Rats (500 mg/kg) + Seed Biflavonoid
Fraction (200 mg/kg)
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LDL-c which was not removed in the process of lipid
metabolism is likely to flow into the subendothelial
space, and subsequently undergo oxidation. The oxi-
dized LDL is phagocytized by the scavengers of macro-
phages and the fat-laden macrophage is left with the
lipid core filled with cholesterol after necrocytosis and
then arteriosclerosis is initiated [27]. This work shows
significant (P < 0.05) reduction in LDL-c levels by all
Garcinia kola biflavonoid fractions (Tables 1 and 2), the
biflavonoid fractions may have increased LDL-c recep-
tors densities in the liver binding to apolipoprotein B
thereby making liver cells more efficient to remove
LDL-c from blood as reported by Baum et al. [28].
HDL-c act as cholesterol scavengers, they pick up
excess cholesterol and cholesterol esters from the blood
and peripheral tissues to the liver where it is broken
down to bile acids. It plays an important role in reducing
blood and peripheral cholesterol concentrations and
inhibits formation of atherosclerotic plaque in the aorta
[29], therefore known as the protective cholesterol. The
present studies show significant (P < 0.05) increase in
HDL-c by root bark and stem bark biflavonoid fractions
(Table 1) and significant (P < 0.05) increase in HDL-c by
seed biflavonoid fraction (Table 2). This could possibly
be due to increasing activity of lecithin-cholesterol acyl
transferase (LCAT), an enzyme responsible for incorp-
orating free cholesterol into HDL-c as suggested by
Geetha et al. [30], there by promoting reverse choles-
terol transport and competitively inhibiting the uptake
of LDL-c by endothelial cells and preventing the
generation of oxidized LDL-c.
Atherogenic risk predictor indices (HDL-c/TC, LDL-c/
HDL-c and log (TG/HDL-c)) are mathematical relation-
ships between TC, TG, LDL-c and HDL-c that have
been successfully used as markers of assessing athero-
sclerosis development [31] and extent of CHDs. HDL-c/
TC ratio greater than 0.3 and LDL-c/HDL-c ratio less
than 2.3 indicate a reduced risk of peripheral arterial
disease [32]. However, log (TG/HDL-c) has been consid-
ered the most accurate in determining the extent of
atherosclerosis and the risk of myocardial infarction
Dobiasova et al. [33]. It has been suggested that log
(TG/HDL-c) values of -0.3 to 0.1 are associated with
low, 0.1 to 0.24 with medium and above 0.24 with high
cardiovascular disease risk [34]. According to these ranges
provided by Ojiakor and Nwanjo [32] for HDL-c/TC and
LDL-c/HDL-c ratios and Dobiasova [34] for log (TG/
HDL-c), the most important atherogenic risk predictor
Table 5 Prophylactic effect of Garcinia kola biflavonoid fractions on body weight of P407 induced hyperlipidemic albino rats





weight (g)Week 1 Week 2 Week 3
NC 70.56 ± 2.40a 68.80 ± 1.44 a 69.32 ± 3.06 a 207.50 235.75 28.50 ± 14.52a
P407 66.92 ± 3.50 a 68.68 ± 1.40 a 68.12 ± 0.61 a 164.00 193.33 29.33 ± 13.87a
ATV + P407 70.80 ± 0.80 a 68.00 ± 2.00 a 70.00 ± 2.00 a 189.75 216.00 26.25 ± 9.21a
RBBF + P407 69.20 ± 1.20 a 67.60 ± 2.12 a 68.92 ± 0.61 a 181.75 229.75 48.00 ± 9.02b
SBBF + P407 67.32 ± 1.20 a 66.68 ± 3.06 a 67.72 ± 2.05 a 184.00 213.50 29.50 ± 11.70a
SBF + P407 65.88 ± 1.70 a 67.48 ± 1.67 a 68.40 ± 1.44 a 193.80 221.60 27.80 ± 10.66a
Values are means ± Standard deviations
Values with different superscripts down the column differ significantly (p < 0.05)
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats (500 mg/kg), ATV + P407 Atorvastatin (10 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg),
RBBF + P407 Root bark Biflavonoid Fraction (200 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg), SBBF + P407 Stem bark Biflavonoid Fraction (200 mg/kg)
+ P407 Induced Hyperlipidemic Rats (500 mg/kg), SBF + P407 Seed Biflavonoid Fraction (200 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg)
Table 6 Therapeutic effect of Garcinia kola biflavonoid fractions on body weight of P407 induced hyperlipidemic albino rats





weight (g)Week 1 Week 2 Week 3
NC 70.56 ± 2.40 a 68.80 ± 1.44 a 69.32 ± 3.06 a 207.50 235.75 28.50 ± 14.52b
P407 66.92 ± 3.50 a 68.68 ± 1.40 a 68.12 ± 0.61 a 164.00 193.33 29.33 ± 13.87b
P407 + ATV 68.12 ± 2.34 a 68.12 ± 2.28 a 68.52 ± 1.29 a 191.33 221.00 29.67 ± 10.01b
P407 + RBBF 68.40 ± 1.44 a 67.32 ± 2.36 a 67.72 ± 2.05 a 189.50 215.00 25.50 ± 12.23b
P407 + SBBF 67.72 ± 2.41 a 66.92 ± 1.66 a 69.60 ± 1.44 a 197.00 216.25 16.75 ± 5.12ab
P407 + SBF 66.67 ± 1.40 a 67.02 ± 1.66 a 67.48 ± 2.20 a 194.67 200.67 6.00 ± 2.64a
Values are means ± Standard deviations
Values with different superscripts down the column differ significantly (p < 0.05)
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats (500 mg/kg), P407 + ATV P407 Induced Hyperlipidemic Rats (500 mg/kg) + Atorvastatin (10 mg/kg),
P407 + RBBF P407 Induced Hyperlipidemic Rats (500 mg/kg) + Root bark Biflavonoid Fraction (200 mg/kg), P407 + SBBF P407 Induced Hyperlipidemic Rats (500 mg/
kg) + Stem bark Biflavonoid Fraction (200 mg/kg), P407 + SBF P407 Induced Hyperlipidemic Rats (500 mg/kg) + Seed Biflavonoid Fraction (200 mg/kg)
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index, all induced animals in both studies are at high
cardiovascular disease risk after intra peritoneal adminis-
tration of 500 mg/kg body weight of P407 with log (TG/
HDL-c) > 0.24 but the biflavonoid fractions did signifi-
cantly (p < 0.05) reduce this risk (Tables 1 and 2) suggest-
ing anti-atherogenic abilities of Garcinia kola (root bark,
stem bark and seeds) biflavonoid fractions, hence reduc-
tion in development of cardiovascular disease.
Kidney helps in maintaining homeostasis of the body
by reabsorbing important material and excreting waste
products [35]. Its function is usually assessed by the
levels of urea and creatinine in the blood; creatinine
being the most specific. Urea is the main end product of
protein catabolism; it varies directly with protein intake
and inversely with the rate of excretion. Renal diseases
which diminish the glomerular filteration lead to urea
retention and decrease in urea is seen in severe liver
disease with destruction of cells leadings to impairment
of the urea cycle [36]. Creatinine is a waste product
formed in muscle by creatine metabolism. Creatinine is
synthesized in the liver, passes into the circulation and is
taken up almost entirely by skeletal muscle. Its retention
in the blood is evidence of kidney impairment. There
was no significant (p > 0.05) change in urea and creatinine
levels of all the groups in both studies (Tables 3 and 4)
indicating no impairment of kidney function by the
administration of P407 and Garcinia kola biflavonoid frac-
tions did not also significantly (p > 0.05) exert any effect.
This work showed no significant (p > 0.05) difference
in feed intake and body weight of the hyperlipidemic
control compared to the normal control (Tables 5 and 6).
A result agreeing with earlier report by Johnston et al. [37]
that P407 does not significantly (p > 0.05) affect body
weight of animals. The non-appreciable rate of weight
gain between the initial and final weights observed in the
seed biflavonoid fraction treated group (Table 6) is in
agreement with earlier reports which attributed it to the
anti-atherogenic effect of Garcinia kola seed biflavonoid
fraction and its anti-adipogenic effect inhibiting accumu-
lation of lipid droplets in fat cells [38–40].
The significantly (p < 0.05) increased liver and spleen
weights in the hyperlipidemic control (Tables 7 and 8)
could be as a result of fatty infiltration and increased
blood cells in the spleen as suggested by Sheyla et al.
[41]. However, all biflavonoid fractions reduced the liver
and spleen weights (Tables 7 and 8). These reductions in
organ weights show the protective or restoring potentials
of the plant biflavonoid fractions on the organs (liver
and spleen).
Conclusion
This study showed Garcinia kola (root bark, stem bark
and seed) biflavonoid fractions can be used in the manage-
ment of hyperlipidemia as the use has no deleterious
effect on kidney function, body and organ weights.
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Table 7 Prophylactic effect of Garcinia kola biflavonoid fractions
on percentage organ weight of P407 induced hyperlipidemic
albino rats
Group (n = 6) Heart (g) Kidney (g) Liver (g) Spleen (g)
NC 0.29 ± 0.03ab 0.55 ± 0.04a 3.25 ± 0.44ab 0.42 ± 0.09a
P407 0.31 ± 0.04b 0.61 ± 0.08a 4.66 ± 0.88c 0.87 ± 0.17b
ATV + P407 0.29 ± 0.02ab 0.55 ± 0.04a 3.57 ± 0.39b 0.44 ± 0.97a
RBBF + P407 0.26 ± 0.02a 0.51 ± 0.08a 2.94 ± 0.12a 0.38 ± 0.08a
SBBF + P407 0.26 ± 0.01a 0.54 ± 0.03a 3.25 ± 0.28ab 0.45 ± 0.06a
SBF + P407 0.28 ± 0.01ab 0.52 ± 0.05a 3.13 ± 0.24ab 0.38 ± 0.05a
Values are means ± Standard deviations
Values with different superscripts down the column differ
significantly (p < 0.05)
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats (500 mg/kg), ATV +
P407 Atorvastatin (10 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg),
RBBF + P407 Root bark Biflavonoid Fraction (200 mg/kg) + P407 Induced
Hyperlipidemic Rats (500 mg/kg), SBBF + P407 Stem bark Biflavonoid Fraction
(200 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg), SBF + P407 Seed
Biflavonoid Fraction (200 mg/kg) + P407 Induced Hyperlipidemic
Rats (500 mg/kg)
Table 8 Therapeutic effect of Garcinia kola Biflavonoid fractions
on percentage organ weight of P407 induced hyperlipidemic
albino rats
Group (n = 6) Heart (g) Kidney (g) Liver (g) Spleen (g)
NC 0.29 ± 0.03a 0.55 ± 0.04a 3.25 ± 0.44a 0.42 ± 0.09a
P407 0.31 ± 0.04a 0.61 ± 0.08a 4.66 ± 0.88b 0.87 ± 0.17c
P407 + ATV 0.29 ± 0.03a 0.59 ± 0.03a 4.37 ± 1.23ab 0.63 ± 0.07b
P407 + RBBF 0.28 ± 0.03a 0.56 ± 0.02a 4.07 ± 0.78ab 0.52 ± 0.05ab
P407 + SBBF 0.27 ± 0.04a 0.56 ± 0.03a 4.19 ± 0.86ab 0.63 ± 0.11b
P407 + SBF 0.30 ± 0.02a 0.57 ± 0.05a 4.33 ± 0.84ab 0.72 ± 0.10b
Values are means ± Standard deviations
Values with different superscripts down the column differ
significantly (p < 0.05)
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats (500 mg/kg), P407
+ ATV P407 Induced Hyperlipidemic Rats (500 mg/kg) + Atorvastatin (10 mg/
kg), P407 + RBBF P407 Induced Hyperlipidemic Rats (500 mg/kg) + Root bark
Biflavonoid Fraction (200 mg/kg), P407 + SBBF P407 Induced Hyperlipidemic
Rats (500 mg/kg) + Stem bark Biflavonoid Fraction (200 mg/kg), P407 + SBF
P407 Induced Hyperlipidemic Rats (500 mg/kg) + Seed Biflavonoid
Fraction (200 mg/kg)
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